Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817160-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
136,625
Total Value
$0.00
P&L
+inf% (+$2,022,050.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Employee Stock Option (right to buy) | Derivative | Feb 10, 2026 | Grant/Award | 93,750 | $0.00 | $0.00 | 93,750 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Units | Derivative | Feb 10, 2026 | Grant/Award | 42,875 | $0.00 | $0.00 | 42,875 | Direct | โ | View Details |